Wistar Scientists Show Telomerase Can Be Successfully Targeted by a Highly Specific Inhibitor
Thursday, September 10, 2015 - 12:00
in Biology & Nature
New research from The Wistar Institute shows exactly how a known, highly selective small molecule telomerase inhibitor is able to bind with the enzyme, thus opening the possibility of developing more telomerase inhibitors that target this pocket of telomerase and could be clinically effective in a wide variety of cancer types.